Banner - NPPA Connect
|Articles|March 1, 2003

Steroid Sparing

Baltimore -- The immunosuppressant agent mycophenolate mofetil (CellCept) should be considered the steroid-sparing drug of choice in the management of pemphigus, according to Daniel Mimouni, M.D.


Latest CME